We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » 2019 in Review: A Flurry of Major Drug Mergers and Acquisitions
2019 in Review: A Flurry of Major Drug Mergers and Acquisitions
2019 was one of the biggest years on record for pharma mergers and acquisitions, including the third largest acquisition of all time — Bristol-Myers Squibb’s $74 billion acquisition of Celgene.